scholarly journals Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

2016 ◽  
Vol 27 (8) ◽  
pp. 1539-1546 ◽  
Author(s):  
K. Yamazaki ◽  
M. Nagase ◽  
H. Tamagawa ◽  
S. Ueda ◽  
T. Tamura ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Iii ◽  
Line Treatment ◽  
First Line ◽  
Phase Iii Study ◽  
First Line Treatment

scholarly journals Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

2014 ◽  
Vol 25 (7) ◽  
pp. 1346-1355 ◽  
Author(s):  
J.Y. Douillard ◽  
S. Siena ◽  
J. Cassidy ◽  
J. Tabernero ◽  
R. Burkes ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Iii ◽  
Line Treatment ◽  
First Line ◽  
Phase Iii Study ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document